95% CI ¼ 1. 20, 2.80 
43).
Conclusions: There is accumulating evidence about the association of waterpipe tobacco smoking with a growing number of health outcomes.
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Background
The past decade has witnessed a steady increase in waterpipe tobacco smoking, especially among the younger age groups.
1,2 A systematic review found that school and university students have the highest prevalence of waterpipe tobacco smoking across countries. 3 In the Global Adult Tobacco Survey 4,5 conducted in 13 low-and middleincome countries, the prevalence of waterpipe use among men was highest in Vietnam (13%) and Egypt (6.2%). Among women, waterpipe use was highest in Russia (3.2%) and Ukraine (1.1%). Even though the Middle Eastern youth are affected the most by the waterpipe smoking epidemic, over the past two decades many studies have reported increase in waterpipe use among youth in North America and Europe. [6] [7] [8] [9] We systematically reviewed the literature in 2008 and found significant associations between waterpipe tobacco smoking and a number of health outcomes. 10 For example, waterpipe tobacco smoking was associated with increased odds of lung cancer [odds ratio (OR) ¼ 2.12] and respiratory disease (OR ¼ 2.30). We also found evidence suggesting clinically significant association with periodontal disease (OR ¼ 3-5) and low birthweight (OR ¼ 2.12).
The available evidence at that time did not allow ruling out or confirming an association between waterpipe tobacco smoking and bladder cancer, nasopharyngeal cancer, oesophageal cancer, oral dysplasia and infertility. Since then, newly published studies have addressed some of these outcomes (e.g. oesophageal carcinoma) [11] [12] as well as additional outcomes [e.g. quality of life, cardiovascular diseases, gastro-oesophageal reflux disease (GERD)]. [13] [14] [15] [16] [17] Therefore, the objective of this study was to update our systematic review of the medical literature on the effects of waterpipe tobacco smoking on health outcomes.
Methods

Eligibility criteria
We included observational studies (i.e. cohort studies, case-control studies and cross-sectional studies). The exposure of interest was waterpipe tobacco smoking and the outcomes of interest were any health outcomes. 
Selection process
Teams of two reviewers independently screened the title and abstract of identified citations for potential eligibility. We acquired the full texts of citations judged as potentially eligible by at least one of two reviewers. Next, two reviewers used a standardized and pilot-tested form to independently screen each full text for eligibility. Disagreements were resolved by discussion or by consulting a third reviewer.
Data abstraction
Teams of two reviewers used a standardized and pilottested form to independently abstract data. Disagreements were resolved by discussion or by consulting a third reviewer. Data abstracted from individual studies included information about study design, population, exposure, outcomes, methodological features, results and funding.
Risk of bias assessment
We have assessed the risk of bias of all the included studies based on the following four commonly used criteria: selection bias; information bias; confounding; and completeness of data. The risk of bias was rated as 'high' in studies that failed three or more of these criteria, 'moderate' in studies that failed one or two criteria and 'low' in studies that failed none of them. To assess selection bias, we reviewed sampling of participants, their recruitment and their representativeness. We have assessed information bias for measurement of exposure and outcome with regard to using validated tools with adequate evidence of validation provided. Confounding assessment was based on whether authors reported controlling for relevant confounders with adequate details (e.g. in the design phase through matching and/or in the analysis through adjustment). Completeness of data was based on whether authors provided information about missing data and participation rate (Appendix 3 & Appendix 4, available as Supplementary data at IJE online).
Data analysis
Agreement between the reviewers was calculated using Cohen's kappa statistic. We conducted meta-analyses for the outcomes for which at least two studies reported effect estimates of their association with waterpipe tobacco smoking. When a study reported more than one relevant effect estimate, we selected the one that adjusted for the maximum number of confounders, particularly for other forms of tobacco smoking. For continuous outcomes using different scales, we calculated the standardized mean difference (SMD) for each study and then pooled across eligible studies using the inverse variance method. For dichotomous outcomes, we used the reported ORs to calculate the Natural logarithm of odds ratios (ln(ORs)) and standard errors. We then pooled the ln(ORs) across eligible studies using the inverse variance method. We used fixed-effects models when pooling only two studies, and used the random-effects model in all other cases. We measured heterogeneity across studies using the I 2 statistic. We considered heterogeneity to be high when I 2 was greater than 50%. We used Review
Manager software Version 5.0.2 for all analyses.
Results
Search results
Appendix 1 shows the study flow. Out of 360 full texts assessed, we excluded 301, with reasons for exclusion provided in Appendix 1. Of the 50 included studies, 24 were identified by the original search and 26 were identified by the update. Agreement between reviewers for study eligibility was excellent (kappa ¼ 0.94 and 0.80 for the two teams). The included studies assessed the associations between waterpipe tobacco smoking and the following outcomes: respiratory diseases (n ¼ 9); quality of life (n ¼ 2); oesophageal cancer (n ¼ 3); gastric carcinoma (n ¼ 3); oral cancer (n ¼ 3); bladder cancer (n ¼ 2); nasopharyngeal cancer (n ¼ 1); lung cancer (n ¼ 6); prostate cancer (n ¼ 1); colorectal cancer (n ¼ 1); pregnancy outcomes (n ¼ 3); periodontal disease (n ¼ 6); hepatitis C infection (n ¼ 3); infertility (n ¼ 1); metabolic syndrome (n ¼ 1); gastrooesophageal reflux disease (GERD) (n ¼ 1); cardiovascular diseases (n ¼ 2); mental health (n ¼ 1); and mortality outcomes (n ¼ 1)
Methodological features
Risk of bias assessment Out of the 50 included studies, only 8 studies were assessed to have selection bias and/or report insufficient information about the sampling techniques, and 16 studies reported the participation rate. There was no agreement across studies on a standardized way to measure exposure to waterpipe tobacco smoking, and this was the main reason for heterogeneity in the meta-analysis. There was agreement across studies on the need to adjust for potential confounders such as age, gender, education and other forms of tobacco use.
Evidence synthesis
Respiratory diseases
Nine studies evaluated the association between waterpipe tobacco smoking and respiratory disease. Five studies assessed the association between waterpipe tobacco smoking and chronic obstructive pulmonary disease (COPD) (four cross-sectional studies and one case-control) ( Figure 3 ). The pooled odds ratio for the association of passive waterpipe tobacco smoking and respiratory illness was 1.97 (95% CI ¼ 1.28, 3.04).
Quality of life
Two cross-sectional studies evaluated the association between waterpipe tobacco smoking and quality of life 13, 26 ( Figure 6 ). [29] [30] [31] Both studies were from Iran. The pooled odds ratio for the association of waterpipe tobacco smoking with gastric carcinoma was OR ¼ 2.16 (95% CI ¼ 0.72, 6.47). The level of statistical heterogeneity was high (I 2 ¼ 61%). One case-control study reported only means, so was not included in the meta-analysis. 31 It reported higher frequency of waterpipe smoking among those with gastric carcinoma (mean ¼ 3 6 1.6) compared with healthy controls (mean ¼ 2 6 1.1; P-value ¼ 0.4).
Oral cancer
Three cross-sectional studies evaluated the association between waterpipe tobacco smoking and oral cancer: one from Yemen and one from India. [41] [42] [43] Figure 7 ).
Bladder cancer
Two case-control studies evaluated the association between waterpipe tobacco smoking and bladder cancer, both of which were conducted in Egypt 32, 33 (Table 1; Appendix 3: Table 3 & Figure 8 ). The pooled odds ratios for the association of waterpipe tobacco smoking with bladder cancer was OR ¼ 1.25 (95% CI ¼ 0.99, 1.57). Figure 9 ). Table 3 ).
Colorectal cancer
One cross-sectional study assessed the association between waterpipe smoking and colorectal cancer, 44 A sample of 120 participants who were recorded on the cancer registry centre of Babol were contacted to fill in a survey about demographics and risk factors including waterpipe use. Among waterpipe smokers, 22.70% of men and 15.80% of women were diagnosed with colorectal-cancer (Table 1 ; Appendix 3, Table 3 ).
Pregnancy outcomes
Two retrospective cohort studies and two case-control studies evaluated the association between waterpipe tobacco smoking and pregnancy outcomes [45] [46] [47] [48] (Table 1; Appendix 3:   Table 4 & Figure 10 ). One study also reported Apgar score, pulmonary problems, malformations and perinatal complications. 46 The pooled OR for the association of waterpipe to- 
Periodontal disease
Of the five studies that evaluated the association between waterpipe tobacco smoking and periodontal disease, [49] [50] [51] [52] [53] four were cross-sectional studies conducted in the same (or in a subgroup of the same) group of participants [49] [50] [51] [52] ( Table 1 ; Appendix 3, Table 5 ). These four studies assessed periodontal disease using different measures (periodontal bone height loss, plaque index and gingivitis, deepening of the sulci or pockets, vertical periodontal bone loss). We did not pool data from the four related studies as they were derived from the same participants. Their results consistently showed a significant association of waterpipe tobacco smoking with periodontal disease (OR ranging 3.00-5.00).
The fifth study was a cohort study with 7 days' followup after surgical removal of mandibular third molars, and evaluated the outcome of dry socket. 53 The reported RR for the association of waterpipe tobacco smoking with dry socket was 3.70 (P ¼ 0.001). Dry socket, or alveolar osteitis, is the most common complication following tooth extractions. It is caused by the dislodgement of the blood clot at the site of the tooth extraction, exposing underlying bone and nerves and causing increasing pain.
Infectious disease
Three cross-sectional studies evaluated the association between waterpipe tobacco smoking and hepatitis C. [54] [55] [56] The three studies were conducted in Egypt and included male participants exposed to group waterpipe tobacco smoking (Table 1 ; Appendix 3: Table 6 & Figure 11 ). The pooled OR for the association of group waterpipe smoking with hepatitis C was 0.98 (95% CI ¼ 0.80, 1.21).There were no eligible studies assessing the association between waterpipe tobacco smoking and the transmission of tuberculosis. The two reports that we found of outbreak investigations suggested an association between tuberculosis and sharing tobacco waterpipes and marijuana waterpipes.
62,63
Infertility
One case-control study evaluated the association between waterpipe smoking and male factor infertility (based on semen analysis) 57 (Table 1 ; Appendix 3, Table 7 ). The reported OR for the association of waterpipe tobacco smoking with male factor infertility was OR ¼ 2.50 (95% CI ¼ 1.00, 6.30).
Metabolic syndrome
One cross-sectional study evaluated the association between waterpipe tobacco smoking and metabolic syndrome. Table 8 ).
Gastro-oesophageal reflux disease
One cross-sectional study evaluated the association between waterpipe tobacco smoking and gastro-oesophageal reflux disease (GERD). 17 The reported odds ratio for the association of waterpipe tobacco smoking with having any gastro-oesophageal reflux disease symptom was 1.25 (95% CI ¼ 1.01, 1.56) (Table 1 ; Appendix 3, Table 8 ).
Cardiovascular disease
Two cross-sectional studies evaluated the association between waterpipe tobacco smoking and cardiovascular disease. 14, 16 In one study, the reported odds ratio for the association between waterpipe tobacco smoking and heart disease was 1.67 (95% CI ¼ 1.25, 2.24). The other study was based on data obtained from a population based cohort study conducted in the Golestan province in Iran, and included individuals between 40 and 75 years old. The reported OR for the association between waterpipe tobacco smoking and heart disease was 3.75 (95% CI ¼ 1.55, 9.22) ( Table 1 ; Appendix 3, Table 8 ).
Mental health
One cross-sectional study, conducted among institutions participating in the national college health assessment of the American College Health Association, evaluated the association between waterpipe tobacco smoking and mental health. 59 All mental health diagnoses were significantly associated with increased rates of waterpipe tobacco smoking, with ORs ranging from 1.30 to 2.40 (Table 1 ; Appendix 3, Table 8 ).
Mortality outcomes
One cohort study associated waterpipe tobacco smoking with mortality outcomes. 15 The first study, Table 8 ).
Discussion
We systematically reviewed the medical literature for the effects of waterpipe tobacco smoking on health outcomes. We found that waterpipe tobacco smoking was associated with respiratory diseases (COPD, bronchitis and wheeze due to exposure to passive waterpipe smoking), oral cancer, lung cancer, low birthweight, metabolic syndrome, cardiovascular disease and mental health. The existing evidence suggested no association with oesophageal cancer, gastric carcinoma, bladder cancer, prostate cancer, hepatitis C infection, periodontal disease, gastro-oesophageal reflux disease, nasopharyngeal carcinoma, bladder cancer, infertility or mortality. Cigarette smoking is known to be a major cause of respiratory diseases through promoting lung function loss and decreasing lung function rates. [64] [65] [66] In a similar manner, waterpipe smoking was associated with significant reduction in forced expiratory volume in 1 s (FEV-1) and forced vital capacity (FVC), by 4.04% and 1.38% respectively, compared with non waterpipe smokers. 67 This suggests an obstructive mechanism, as was similarly reported by Chaouchi et al. who have shown that chronic use of a waterpipe with one or more smoking sessions per day can lead to COPD. 68 This result is also in agreement with the reported estimates that tobacco smoking increases the risks of death from lung cancer or COPD by 20-fold. 6 Another mechanism for the effect of waterpipe smoking on respiratory outcomes was found to be through the damage that it causes to the lung parenchyma and the associated inflammation of the airways. 69, 70 Tobacco was found to be a source of 69 carcinogens and has been widely associated with increasing the risk of developing cancers and malignancies. 6, 71 Thus, strong associations have been established between cigarette smoking and different cancers, particularly in the lungs and the digestive system. 65, 66, [72] [73] [74] [75] These results can also be extended to include waterpipe smoking, as has been reported by a study of 56 chronic Pakistani waterpipe smokers that found markedly increased levels of carcinoembryonic antigen (CEA) as compared with non-smokers (P < 0.0001).
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CEA is known to be elevated in lung, pancreatic, uterus and breast cancers as well as in cases of chronic inflammation. Other studies also reported increased risk of carcinogenesis among waterpipe smokers due to genotoxic and clastogenic components in the waterpipe smoke, such as tar and polycyclic aromatic hydrocarbons. 69, 77 This likely explains the association between waterpipe tobacco smoking and cancers outside the lung such as prostate cancer, an association previously shown between cigarette smoking and prostate cancer. 78, 79 There is also evidence that smoking induces hormonal changes in men that could affect the risk of prostate cancer. 80 The effects of tobacco on atherosclerosis have been attributed to various mechanisms that promote atherosclerosis and endothelial dysfunction. 6, 81 Cigarette smoking has been associated with cardiovascular disease through promoting atherosclerosis and being highly dose related. [81] [82] [83] Similarly, a comparative double-blinded study done on 37 waterpipe smokers who reported smoking a waterpipe 2-5 times/month showed increased mean (6 SEM) plasma nicotine concentration (3.6 6 0.7 ng/ml) and heart rate (8.6 6 1.4 bpm) as compared with placebo (0.1 6 0.0 ng/ml; 1.3 6 0.9 bpm), indicating that the effects of waterpipe smoking on cardiovascular outcomes are mediated by its nicotine content. 84 Some studies also attributed the deleterious effects of waterpipe smoking on cardiovascular disease to in vivo oxidation injury and systemic inflammation that increases the likelihood of atherosclerosis and arrhythmia.
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Strengths and limitations
To our knowledge, no systematic reviews have been conducted on the association between waterpipe smoking and health outcomes since our earlier review in 2010. Further strengths of the review include adhering to the Cochrane Collaboration methodology, which is considered the gold standard for systematically reviewing literature, using a sensitive search strategy and conducting screening and data extraction independently and in duplicate. The confidence in the effects estimates in this systematic review is affected by a number of limitations. Indeed, five out of 11 meta-analyses suffered from a high degree of heterogeneity, namely oesophageal carcinoma, gastric carcinoma, low birthweight, COPD and quality of life. Also, Appendix 3 shows the methodological limitations of the included studies. Most of the studies used non-validated tools for measurement of waterpipe tobacco exposure, which is a major limitation given that the practice of waterpipe tobacco smoking can vary widely according to the quantity of tobacco used, the frequency and the length of the session.
We were not able to conduct meta-analyses for all outcomes. One reason was the high level of heterogeneity, as was the case for the quality of life outcome. Another reason was that we could not pool several outcomes derived from the same study, as was the case for the metabolic syndrome, nasopharyngeal carcinoma, gastro oesophageal reflux disease, mental health and mortality outcomes.
Additional research implications of our findings include the need for more research on this topic using validated tools for measurement of both the exposure and the outcome of interest. There is also a need to investigate the effect of second-hand exposure due to the amount of smoke generated by a waterpipe.
Our findings have both clinical and public health implications. Our findings reinforce the message that all forms of smoking are unsafe, and clinicians should be clear about delivering this unified message to patients. Given the available evidence, public health agents and policy makers need not wait for more evidence to enact and implement laws, and develop public health programmes to reduce waterpipe tobacco use, particularly among youth. This is particularly relevant given the emerging evidence that waterpipe tobacco smoking may predict cigarette initiation and thus serve as a gateway to cigarette smoking. 88 
